Levitas’s 90-day longevity plan aims to add decades, with a mix of detox, peptides and ‘sexual optimization’

A London longevity clinic is marketing a 90-day programme it says can reset the body to its natural state, banish chronic inflammation and, over time, add decades to a life. The package, priced at about £3,000 for the initial phase, rests on a philosophy that inflammation underpins most disease and that the body can be rebooted through detox, regenerative therapies and lifestyle shifts. Dr Ash Kapoor, a former NHS GP who founded the Levitas Clinic, frames inflammation as the root cause of illness and argues that genes do not dictate destiny. He contends that, with the right protocol, people can reverse health trajectories and extend their active years well beyond what is typical today.

Kapoor’s approach blends a broad menu of therapies and practices under a single umbrella of regenerative medicine. The Levitas protocol features light therapy, shockwave sessions described as “acupuncture on steroids,” facial and body treatments, a blue compression suit, and even a state-of-the-art dental cleaning, all alongside aesthetic and regenerative interventions such as hair rejuvenation. A key element is a body composition test that measures fat, muscle, sugar levels and, crucially, the body’s ketone count to gauge autophagy—the process by which the body recycles damaged components and reduces inflammation. Kapoor argues that achieving an autophagic state helps reduce disease risk and may alter lifelong health trajectories. The concept underpins his claim that, with a 90-day reset, many problems can be diminished or eliminated and health preserved for decades.

The visit to Kapoor’s Mayfair clinic begins with a specialist consultation. The interviewer undergoes the same starting point as new patients: a body composition assessment described as turning you “inside out.” The test involves standing on a monitor and holding two paddles to measure fat, muscle structure and metabolic markers, with particular attention paid to ketone levels as a proxy for metabolic efficiency and autophagy. The narrator learns that, while some patients arrive overweight, others are not seriously obese but are seeking renewed energy and mental clarity. A seven-week course of premium Australian herbs is proposed to detox the small intestine, followed by a liver detox to boost energy, a three-day water fast, and seven days with one small meal per day. The plan then shifts to rebuilding the body with peptides, breathwork and ice baths, with Kapoor promising sleep improvements and a potential “20 years” of added lifespan. He emphasizes that the aim is not merely longer life but a higher quality of life, with patients reportedly adopting calmer, more community-centered outlooks after their reset.

The session also introduces a suite of more controversial procedures. An anti-inflammatory turmeric drip is administered, and Kapoor describes ADHD as a byproduct of the body’s failure to process sugar efficiently. He asserts that conditions such as rheumatoid arthritis, colitis, high blood pressure, Alzheimer’s disease and autoimmune disorders can be managed through this framework. In a striking example of his broader portfolio, a hair-rejuvenation session uses a serum derived from trout sperm to stimulate follicle activity, which Kapoor says signals the body to re-engage its growth processes. A further treatment involves injecting carbon dioxide into the eye sockets to reduce under-eye bags for a few weeks. Kapoor says the regimen is designed not only to improve appearance but to catalyze systemic improvements by shifting the body toward a regenerative, less inflamed state.

The doctor’s background and ambitions are notable. He left clinical practice in the NHS after years prescribing chronic disease medications and says he found prescribing for the ill “depressing,” which led him to explore natural and regenerative pathways. He travels internationally to study epigenetics, peptides and longevity therapies and has built a high-end personal brand around Levitas, including a luxury lifestyle image that includes a Bentley and a driver. He maintains that his approach works not just for those undertaking the 90-day programme but beyond, citing anecdotes of patients who continue to lose weight, regain energy and pursue ambitious projects after completing the initial course. He contends that the programme helps people move away from an ego-driven, material perspective toward community and well-being, and he argues that many patients are fixable regardless of age.

The narrative of Kapoor’s programme has spread largely through word of mouth. He describes a client base that includes high-net-worth individuals in their 60s dealing with burnout, as well as younger patients seeking a different path to vitality. He emphasizes that the process can involve people who are not visibly ill and those who want a “new way” of living, saying his patients can be inspired to adopt long-term habits such as breathwork, ice baths and barefoot walking in parks, along with a simplified diet and one-meal-a-day schedules. For some, the results are framed as transformative in personal and professional dimensions, including the ability to re-enter active work and social life with renewed energy.

The programme’s appeal is further illustrated by Donal MacIntyre, the journalist who previously reported on Kapoor’s methods. MacIntyre, who lost more than three stone in a 23-day fast under Kapoor’s supervision, described a near-rebirth experience, noting improvements in blood pressure, the cessation of pre-diabetes symptoms and the avoidance of knee surgery. Kapoor presents cases like MacIntyre’s as proof that the approach can yield meaningful health benefits, especially for those who were formally considered chronically ill or at risk for metabolic disease.

Still, the claims surrounding the Levitas approach have drawn scrutiny. Critics and medical experts say that while some patients may enjoy short-term improvements in energy or appearance, the broader claims—reversing aging, drastically reducing disease risk for all conditions or guaranteeing long-term health—require robust, independent scientific validation. The programme’s price point—about £3,000 for the initial 90-day protocol plus potential add-ons—belongs to a market of longevity ventures that often tout dramatic life-extension benefits with varying degrees of evidence. Kapoor argues that his method avoids the high costs of biotech therapies used by some peers and emphasizes lifestyle and metabolic resetting as a practical path to better health rather than speculative, experimental interventions. Whether the regimen offers durable, generalizable health gains remains a question for longer-term studies and broader medical consensus.

For readers considering such programmes, medical professionals commonly advise caution and emphasize that evidence-based approaches—regular medical screening, proven treatments for chronic diseases, and balanced diet and exercise—remain the foundation of public-health recommendations. Consumers should be wary of claims that promise extreme longevity or disease reversal without independent, peer-reviewed data to support them. Individual experiences can vary, and what works for one person may not work for another, especially when a regimen includes injections, intravenous therapies and restrictive fasting schedules.

As for the journalist who embarked on Kapoor’s intake, the experience raises questions about weighing cost, time, risk and personal values in pursuing longevity. The article ends with a personal contemplation: would the potential benefits justify the investment, and would the prospect of living to 123—or beyond—be something worth pursuing if family and friends do not share in the extended years? For now, the Levitas plan remains one option among a spectrum of evolving, often controversial, approaches to health, aging and personal vitality. The question, as ever, is how much evidence and how much personal conviction a person is willing to trade for the possibility of a longer, more vibrant life.